Development and initial characterization of a chemically stabilized elastin-glycosaminoglycan-collagen composite shape-memory hydrogel for nucleus pulposus regeneration

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 12, 2014, Pages 4380-4393

  Mercuri, Jeremy ^a   Addington, Caroline ^a   Pascal, Richard ^a   Gill, Sanjitpal ^a,b   Simionescu, Dan ^a  

^a Clemson University   (United States)

^b Gibbs Cancer Center and Research Institute   (United States)

Author keywords

Biopolymer; Hydrogel; Nucleus pulposus; Stem cells; Tissue regeneration

Indexed keywords

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; BIOPOLYMERS; BLENDING; CELLS; COLLAGEN; CYTOLOGY; ELASTIN; GLYCOPROTEINS; HYALURONIC ACID; HYDROGELS; HYDROPHILICITY; STEM CELLS; TISSUE;

BIOMECHANICAL FUNCTIONS; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRICES; HUMAN ADIPOSE DERIVED STEM CELLS; HYDROPHILIC HYDROGELS; INTERVERTEBRAL DISCS; MECHANICAL COMPRESSION; NUCLEUS PULPOSUS;

TISSUE REGENERATION;

BIOMATERIAL; CHONDROITIN 6 SULFATE; COLLAGEN; CYANAMIDE; ELASTIN; FIXATIVE; GLYCOSAMINOGLYCAN; HYALURONIC ACID; NANOCOMPOSITE; HYDROGEL;

ADIPOSE DERIVED STEM CELL; ARTICLE; BIOCOMPATIBILITY; BIOMECHANICS; COMPRESSION; ELASTIN GLYCOSAMINOGLYCAN COLLAGEN COMPOSITE SHAPE MEMORY HYDROGEL; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRIX; FEASIBILITY STUDY; FREEZE DRYING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROGEL; IN VITRO STUDY; MINIMALLY INVASIVE PROCEDURE; NUCLEUS PULPOSUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE REGENERATION; WATER CONTENT; ADIPOSE TISSUE; BIODEGRADABLE IMPLANT; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; INTERVERTEBRAL DISK; METABOLISM; PHARMACOLOGY; REGENERATION; STEM CELL;

ABSORBABLE IMPLANTS; ADIPOSE TISSUE; CELLS, CULTURED; COLLAGEN; ELASTIN; GLYCOSAMINOGLYCANS; HUMANS; HYDROGELS; INTERVERTEBRAL DISC; REGENERATION; STEM CELLS;

EID: 84911808262     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35104     Document Type: Article

References (50)

1. Freemont AJ. The cellular pathobiology of the degenerate intervertebral disc and discogenic back pain. Rheumatology (Oxford) 2009;48:5-10.
2. Katz JN. Lumbar disc disorders and low-back pain: Socioeconomic factors and consequences. J Bone Joint Surg Am 2006; 88(Suppl 2):21-24.
3. An HS, Thonar EJ, Masuda K. Biological repair of intervertebral disc. Spine 2003;28(15 Suppl):S86-S92.
4. Yoon T. Louis-Ugbo J. Molecular therapy of the intervertebral disc. In: Szpalski M, Gunzburg R, LeHuec J, Brayda-Bruno M, editors. Non-fusion Technologies in Spine Surgery. New York: Lippincott, Williams & Wilkins; 2007.
5. Boos N, Weissbach S, Rohrbach H, Weiler C, Spratt KF, Nerlich AG. Classification of age-related changes in lumbar intervertebral discs: 2002 Volvo Award in basic science. Spine (Phila Pa 1976) 2002;27:2631-2644.
6. Haefeli M, Kalberer F, Saegesser D, Nerlich A, Boos N, Paesold G. The course of macroscopic degeneration in the human lumbar intervertebral disc. Spine 2006;31:1522-1531.
7. Mow VC, Hayes WC. Basic Orthopaedic Biomechanics, 2nd ed. Philadelphia: Lippincott - Raven; 1997.
8. Ahrens M, Tsantrizos A, Donkersloot P, Martens F, Lauweryns P, Le Huec JC, Moszko S, Fekete Z, Sherman J, Yuan HA, Halm H. Nucleus replacement with the DASCOR disc arthroplasty device: Interim two-year efficacy and safety results from two prospective, non-randomized multicenter European studies. Spine (Phila Pa 1976) 2009;34:1376-1384.
9. Bao QB, Bagga CS, Higham PA. Swelling pressure of hydrogel: A perceived benefit for a spinal prosthetic nucleus. In: 10th Annual Meeting of the International Intradiscal Therapy Society. Naples, FL.May 28-31; 1997.
10. Bertagnoli R. Sabatino CT, Edwards JT, Gontarz GA, Prewett A, Parsons JR. Mechanical testing of a novel hydrogel nucleus replacement implant. Spine J 2005;5:672-681.
11. Bertagnoli R, Schonmayr R. Surgical and clinical results with the PDN prosthetic disc-nucleus device. Eur Spine J 2002;11(Suppl 2): S143-S148.
12. Boelen EJ, van Hooy-Corstjens CS, Bulstra SK, van Ooij A, van Rhijn LW, Koole LH. Intrinsically radiopaque hydrogels for nucleus pulposus replacement. Biomaterials 2005;26:6674-83.
13. Joshi A, Fussell G, Thomas J, Hsuan A, Lowman A, Karduna A, Vresilovic E, Marcolongo M. Functional compressive mechanics of a PVA/PVP nucleus pulposus replacement. Biomaterials 2006; 27:176-184.
14. Thomas J, Gomes K, Lowman A, Marcolongo M. The effect of dehydration history on PVA/PVP hydrogels for nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater 2004;69:135-40
15. Thomas J, Lowman A, Marcolongo M. Novel associated hydrogels for nucleus pulposus replacement. J Biomed Mater Res A 2003;67:1329-1337.
16. Vernengo J, Fussell GW, Smith NG, Lowman AM. Evaluation of novel injectable hydrogels for nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater 2008;84:64-69.
17. Baer AE, Wang JY, Kraus VB, Setton LA. Collagen gene expression and mechanical properties of intervertebral disc cell-alginate cultures. J Orthop Res 2001;19:2-10.
18. Boyd LM, Carter AJ. Injectable biomaterials and vertebral endplate treatment for repair and regeneration of the intervertebral disc. Eur Spine J 2006;15(Suppl 3):S414-S421.
19. Calderon L, Collin E, Velasco-Bayon D, Murphy M, O'Halloran D, Pandit A. Type II collagen-hyaluronan hydrogel-A step towards a scaffold for intervertebral disc tissue engineering. Eur Cell Mater 2010;20:134-148.
20. Chou AI, Akintoye SO, Nicoll SB. Photo-crosslinked alginate hydrogels support enhanced matrix accumulation by nucleus pulposus cells in vivo. Osteoarthritis Cartilage 2009;17:1377-1384.
21. Halloran DO, Grad S, Stoddart M, Dockery P, Alini M, Pandit AS. An injectable cross-linked scaffold for nucleus pulposus regeneration. Biomaterials 2008;29:438-447.
22. Le Visage C, Yang SH, Kadakia L, Sieber AN, Kostuik JP, Leong KW. Small intestinal submucosa as a potential bioscaffold for intervertebral disc regeneration. Spine 2006;31:2423-2430; discussion 2431.
23. Li CQ, Huang B, Luo G, Zhang CZ, Zhuang Y, Zhou Y. Construction of collagen II/hyaluronate/chondroitin-6-sulfate tri-copolymer scaffold for nucleus pulposus tissue engineering and preliminary analysis of its physico-chemical properties and biocompatibility. J Mater Sci Mater Med 2009;21:741-51.
24. Roughley P, Hoemann C, DesRosiers E, Mwale F, Antoniou J, Alini M. The potential of chitosan-based gels containing intervertebral disc cells for nucleus pulposus supplementation. Biomaterials 2006;27:388-396.
25. Wardlaw D. BioDisc nucleus pulposus replacement. In: Yue J, Bertagnoli R, McAfee P, An H, editors. Motion Preservation Surgery of the Spine: Advanced Techniques and Controversies. Elsevier: Philadelphia; 2008. p 431-441.
26. Yang SH, Chen PQ, Chen YF, Lin FH. Gelatin/chondroitin-6-sulfate copolymer scaffold for culturing human nucleus pulposus cells in vitro with production of extracellular matrix. J Biomed Mater Res B Appl Biomater 2005;74:488-494.
27. Yang SH, Wu CC, Shih TT, Chen PQ, Lin FH. Three-dimensional culture of human nucleus pulposus cells in fibrin clot: comparisons on cellular proliferation and matrix synthesis with cells in alginate. Artif Organs 2008;32:70-73.
28. Yu J. Elastic tissues of the intervertebral disc. Biochem Soc Trans 2002;30: 848-52.
29. Mercuri JJ, Gill SS, Simionescu DT. Novel tissue-derived biomimetic scaffold for regenerating the human nucleus pulposus. J Biomed Mater Res A 2011;96:422-435.
30. Kielty CM, Sherratt MJ, Shuttleworth CA. Elastic fibres. J Cell Sci 2002;115:2817-2828.
31. Roughley PJ. Biology of intervertebral disc aging and degeneration: involvement of the extracellular matrix. Spine 2004;29:2691-2699.
32. Betre H, Ong SR, Guilak F, Chilkoti A, Fermor B, Setton LA. Chondrocytic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials 2006;27:91-99.
33. Betre H, Setton LA, Meyer DE, Chilkoti A. Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules 2002;3:910-916.
34. McHale MK, Setton LA, Chilkoti A. Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng 2005;11:1768-1779.
35. Moss IL, Gordon L, Woodhouse KA, Whyne CM, Yee AJ. A novel thiol-modified-hyaluronan and elastin-like polypetide composite material for tissue engineering of the nucleus pulposus of the intervertebral disc. Spine (Phila Pa 1976) 2011;36:1022-1029.
36. Berlemann U, Schwarzenbach O. An injectable nucleus replacement as an adjunct to microdiscectomy: 2 year follow-up in a pilot clinical study. Eur Spine J 2009;18:1706-1712.
37. Cloyd JM, Malhotra NR, Weng L, Chen W, Mauck RL, Elliott DM.. Material properties in unconfined compression of human nucleus pulposus, injectable hyaluronic acid-based hydrogels and tissue engineering scaffolds. Eur Spine J 2007;16:1892-1898.
38. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986;883:173-177.
39. Tu Y, Weiss AS. Glycosaminoglycan-mediated coacervation of tropoelastin abolishes the critical concentration, accelerates coacervate formation, and facilitates spherule fusion: implications for tropoelastin microassembly. Biomacromolecules 2008;9:1739-1744.
40. Wu WJ, Vrhovski B, Weiss AS. Glycosaminoglycans mediate the coacervation of human tropoelastin through dominant charge interactions involving lysine side chains. J Biol Chem 1999;274: 21719-21724.
41. Isenburg JC, Karamchandani NV, Simionescu DT, Vyavahare NR. Structural requirements for stabilization of vascular elastin by polyphenolic tannins. Biomaterials 2006;27:3645-3651.
42. Narayanan AS, Anwar RA. The specificity of purified porcine pancreatic elastase. Biochem J 1969;114:11-17.
43. Kafienah W, Buttle DJ, Burnett D, Hollander AP. Cleavage of native type I collagen by human neutrophil elastase. Biochem J 1998;330: 897-902.
44. Goupille P, Jayson MI, Valat JP, Freemont AJ. Matrix metalloproteinases: The clue to intervertebral disc degeneration? Spine (Phila Pa 1976) 1998;23:1612-1626.
45. Le Maitre CL, Freemont AJ, Hoyland JA. Localization of degradative enzymes and their inhibitors in the degenerate human intervertebral disc. J Pathol 2004;204:47-54.
46. Roberts S, Caterson B, Menage J, Evans EH, Jaffray DC, Eisenstein SM. Matrix metalloproteinases and aggrecanase: Their role in disorders of the human intervertebral disc. Spine (Phila Pa 1976) 2000;25:3005-3013.
47. Rutges JP, Kummer JA, Oner FC, Verbout AJ, Castelein RJ, Roestenburg HJ, Dhert WJ, Creemers LB. Increased MMP-2 activity during intervertebral disc degeneration is correlated to MMP- 14 levels. J Pathol 2008;214:523-530.
48. Sekiya I, Vuoristo JT, Larson BL, Prockop DJ. In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis. Proc Natl Acad Sci USA 2002; 99:4397-4402.
49. Clark RA. Skin-resident T cells: The ups and downs of on site immunity. J Invest Dermatol 2009;130:362-370.
50. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, Heath WR, Carbone FR, Mueller SN. Different patterns of peripheral migration by memory CD41 and CD81 T cells. Nature 2011;477: 216-219.